Cargando…

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial

BACKGROUND: SGLT2 (sodium-glucose cotransporter-2) inhibitors improve heart failure–associated outcomes in patients with type 2 diabetes. In patients with heart failure, SGLT2 inhibitors will likely be coprescribed with a loop diuretic, but this combined effect is not well-defined. Our aim was to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordi, Natalie A., Mordi, Ify R., Singh, Jagdeep S., McCrimmon, Rory J., Struthers, Allan D., Lang, Chim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594536/ https://www.ncbi.nlm.nih.gov/pubmed/32865004 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048739

Ejemplares similares

Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017)

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
por: Singh, Jagdeep S. S., et al.
Publicado: (2016)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
por: Steggall, Abbey, et al.
Publicado: (2017)

Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study
por: Brown, Alexander J.M., et al.
Publicado: (2017)

SGLT inhibitor adjunct therapy in type 1 diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2018)

Nicorandil‐induced colovesical fistula in a patient with diverticular disease
por: Noyes, James D., et al.
Publicado: (2021)

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
por: Singh, Jagdeep S.S., et al.
Publicado: (2020)

Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study
por: Mordi, Ify R., et al.
Publicado: (2021)

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
por: Brown, Alexander J M, et al.
Publicado: (2020)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Bicuspid Aortic Valve Disease: A Comprehensive Review
por: Mordi, Ify, et al.
Publicado: (2012)

Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases
por: Mordi, Ify R., et al.
Publicado: (2020)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021)

The Receding Year
Publicado: (1877)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK
por: Mordi, Ify R., et al.
Publicado: (2020)

Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
por: Mordi, Ify R, et al.
Publicado: (2017)

Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction
por: Akbar, Naveed, et al.
Publicado: (2021)

The combined incremental prognostic value of left ventricular ejection fraction, late gadolinium enhancement and global circumferential strain assessed by cardiovascular magnetic resonance
por: Mordi, Ify, et al.
Publicado: (2015)

Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy
por: Mordi, Ify, et al.
Publicado: (2015)

Teeth Receding in Vulcanization
por: Snow, Geo. B.
Publicado: (1905)

Plasma desmosine for prediction of outcomes after acute myocardial infarction
por: Ali, Kashan, et al.
Publicado: (2022)

Glucose Sensing During Hypoglycemia: Lessons From the Lab
por: McCrimmon, Rory
Publicado: (2009)

Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review
por: van Poelgeest, Eveline P., et al.
Publicado: (2023)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Zhou, Yiling, et al.
Publicado: (2021)

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)

Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
por: Pagnesi, Matteo, et al.
Publicado: (2021)

Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
por: Curran, Fraser M., et al.
Publicado: (2021)

Consequences of recurrent hypoglycaemia on brain function in diabetes
por: McCrimmon, Rory J.
Publicado: (2021)

Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes
por: McCrimmon, Rory J.
Publicado: (2022)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Loop Diuretics in Clinical Practice
por: Oh, Se Won, et al.
Publicado: (2015)

Novel Intranasal Loop Diuretic
por: Esque, Benjamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmjiru5qcgaks1ce3tascs7ndi